All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.

  TRANSLATE

The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The Solid Organ Transplantation Hub is an independent medical education platform, sponsored by Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

CLAD monitoring and management practices across North American lung transplantation centers

By Megan Moore

Share:

Oct 7, 2026

Learning objective: After reading this article, learners will be able to cite a new clinical development in lung transplantation.


Results from a Cystic Fibrosis-Lung Transplant Consortium (CFLTC) study, characterizing chronic lung allograft dysfunction (CLAD) monitoring and management practices across 21 North American lung transplantation centers, were published in the Journal of Heart and Lung Transplantation by Kapnadak et al. A 35-question REDCap survey was distributed to centers and addressed immunosuppression regimens, monitoring and testing for graft function and CLAD risk factors, and centers’ approach to lung function decline that persisted after management of acute clinical entities. 

Key data: All 21 centers utilized tacrolimus + mycophenolate mofetil + prednisone for routine immunosuppression. Prophylactic azithromycin was routinely used by 33.3% of centers. In terms of utility, 38.1% of centers reported a belief that azithromycin prevents loss of lung function and 57.1% were uncertain of its effectiveness. Gastroesophageal reflux (GER) testing was performed for all patients before and after lung transplantation in 33.3% of centers. Of 19 centers that responded to questions on proton pump inhibitor (PPI) use, 63.2% routinely prescribed PPIs to all recipients. A persistent forced expiratory volume in 1 second (FEV₁) decline ≥10% was considered clinically meaningful by 71.4% of centers. However, intervention strategies varied, with intravenous corticosteroids and additional immunosuppression agents considered by 66.7% and 61.9% of centers, respectively, for a 10–20% FEV₁ decline, and extracorporeal photopheresis (ECP) and additional immunosuppression agents considered by 81.0% and 66.7% of centers, respectively, for a >20% decline. 

Key learning: In this study, heterogeneity was observed across North American adult lung transplantation centers in azithromycin practices, GER testing and management, and FEV₁ intervention thresholds, highlighting critical knowledge gaps and the need for prospective studies to inform evidence-based CLAD prevention and management. 

References

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content

This content is accurate as of the date of publication and is not updated retrospectively. Please refer to the latest available evidence, guidelines, and relevant regulatory information when making clinical decisions.

Your opinion matters

Which topic, relating to ECP, do you think would be the most valuable educational content for the SOT Hub?